<DOC>
	<DOCNO>NCT02356588</DOCNO>
	<brief_summary>The purpose study compare efficacy safety sublingual Sufentanil Tablet ( ST ) 30 mcg sublingual Placebo Tablet ( PT ) short-term management moderate-to-severe acute post-operative pain patient abdominal surgery .</brief_summary>
	<brief_title>A Trial Evaluating Efficacy Safety Sublingual Sufentanil Tablet 30 mcg Post-Operative Pain After Abdominal Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>Inclusion Criteria ( additional criterion specify ) : 1 . Patients schedule undergo one follow procedure general anesthesia spinal anesthesia include intrathecal opioids operation : abdominoplasty open tensionfree inguinal hernioplasty ( Lichenstein repair mesh ) laparoscopic abdominal surgery 2 . Patients classified American Society Anesthesiologists ( ASA ) class I III ( Appendix I ) . 3 . Female patient childbearing potential must use effective method birth control time screen visit 4 . Patients expect moderatetosevere postoperative pain least 24 hour . Exclusion Criteria ( additional criterion specify ) : 1 . Patients take opioid 30 consecutive day , daily dose 15 mg morphine ( equivalent ) , within past 3 month prior surgery 2 . Patients currently take monoamine oxidase inhibitor ( MAOIs ) take MAOIs within 14 day first dose study drug . 3 . Patients current sleep apnea document sleep laboratory study home continuous positive airway pressure ( CPAP ) . 4 . Patients previously abdominoplasty inguinal hernia repair side .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>